Abstract
Purpose
Idiopathic uveitis is frequently the most common diagnosis in series from uveitis clinics. We sought to determine the percentage of patients initially diagnosed as idiopathic, non-infectious uveitis referred to a tertiary uveitis center who were subsequently found to have an identifiable cause of uveitis.
Design
Retrospective case series.
Methods
We performed a computerized database analysis of 179 consecutive patients who were referred to our practice with the diagnosis of idiopathic, non-infectious uveitis between 2008 and 2016. Patients were evaluated by a thorough history and ophthalmic examination with selected laboratory testing targeted by clues from the history and exam. Standardization of Uveitis Nomenclature (SUN) criteria1 were used to better assess different types of uveitis.
Results
Fifty-two out of 179 (29.0%) patients initially diagnosed with idiopathic uveitis were subsequently diagnosed with an underlying condition. Among patients referred with a diagnosis of idiopathic disease, females were most commonly affected with 121/179 (67.6%). Among subsequent diagnoses, sarcoidosis was the most common (19/52 or 36.5%), followed by HLA-B27 associated uveitis (11/52, 21.1%), infectious (6/52,11.5%), tubulo-interstitial nephritis with uveitis (6/52, 11.5%), and juvenile idiopathic uveitis (4/52, 7.7%). Other diagnosable conditions included Behcet’s disease, multifocal choroiditis and pan-uveitis, Crohn’s disease, multiple sclerosis, and relapsing polychondritis. An underlying condition was not found in 127/179 (70.9%) patients.
Conclusions
We report that 29% of patients referred to our tertiary uveitis center diagnosed as “idiopathic” had an associated identifiable cause. Identifying an underlying condition associated with uveitis could be potentially lifesaving for some illnesses (eg. sarcoidosis with cardiac involvement) and is critical to management (eg. infection). Although we were able to use limited testing to classify many patients who had been previously incorrectly labeled with idiopathic uveitis, idiopathic uveitis remains the most common diagnosis in our uveitis clinic.
Introduction
Uveitis may require a potentially complicated treatment regimen that may be unfamiliar to many ophthalmologists. Uveitis labeled as idiopathic adds further to this feeling of discomfort because it implies that the physician does not understand the disease process. Some experts in the field prefer the term undifferentiated uveitis with descriptors for the course, laterality, and anatomic location because most non-infectious forms of uveitis associated with a systemic disease such as sarcoidosis or ankylosing spondylitis are still thought to be idiopathic, i.e. the pathogenesis of these systemic illnesses is incompletely understood.1 Another proposal is to describe uveitis as classified if it is associated with an identifiable cause such as herpes simplex, sarcoidosis, or ankylosing spondylitis.2 Using this nomenclature, idiopathic uveitis becomes known as unclassified uveitis.
Unfortunately, idiopathic is the most common diagnosis in most series at tertiary uveitis centers across the United States.3–9 Three recent prominent randomized controlled trials confirmed the high prevalence of this diagnosis.9–11 Other recent studies have identified causes of uveitis for inflammation that was previously deemed to be idiopathic. Tubulointerstitial nephritis and uveitis (TINU) syndrome and sarcoidosis are examples of diagnoses that are sometimes established in patients who were previously deemed to have idiopathic disease. 10, 11 We examined records from a tertiary referral center, the Uveitis Clinic at Oregon Health & Science University. We sought to determine how frequently a more precise diagnosis can be ascertained for patients with a referral diagnosis of idiopathic uveitis. In addition, we wanted to know the relative frequency for the diagnoses that replaced idiopathic uveitis.
Methods
A retrospective cohort study was conducted on all patients with a referral diagnosis of idiopathic uveitis seen in the Uveitis Clinic of one of the authors (JTR) at Oregon Health & Science University between the years of 2008 and 2016. All patients were referred by ophthalmologists without specialized training in uveitis. The work up initiated by each referring physician was variable and limited. The only inclusion criteria for the study was a referral diagnosis of “idiopathic uveitis”. Informed consent was not obtained because this was a retrospective review of medical charts. Approval for this chart review was obtained from the OHSU Institutional Review Board.
A complete history and comprehensive ophthalmic examination were performed at the first visit for each patient. Ophthalmic imaging tests such as fluorescein angiography, indocyanine green angiography, optical coherence tomography, and ultrasound were performed as clinically indicated for each case. Ordering of ancillary laboratory and imaging tests was guided by the history and examination findings.
For most patients, a diagnosis was determined primarily on the basis of history and clinical examination. Patients were anatomically classified according to the Standardization of Uveitis Nomenclature (SUN) criteria.12 Specifically, we would classify it as anterior, intermediate, posterior, or pan-uveitis. We would further classify the uveitis by the type of onset (sudden or insidious), laterality (unilateral, bilateral simultaneous, bilateral alternating), course (acute, recurrent, or chronic), and duration (limited or persistent). Categorizing the type of uveitis would help us form a proper differential diagnosis. Laboratory and imaging findings aided in making a diagnosis in certain diagnoses including sarcoidosis, TINU, and HLA-B27-related disease. The diagnosis of idiopathic uveitis was used to describe patients in whom an etiologic diagnosis was not able to be established. Patients were given a diagnosis of presumed sarcoidosis based on chest computed tomography (CT) or radiography findings, features of uveitis consistent with the diagnosis in accord with the recommendations of the International Workshop on Ocular Sarcoidosis (IWOS), and clues from the history and review of systems suggestive of the diagnosis.13 Human leukocyte antigen (HLA)-B27-associated uveitis was established with the aid of positive testing for the HLA-B27 allele and a consistent phenotype of uveitis with most of the following characteristics: unilateral, anterior, recurrent, lasting less than 3 months per episode.14 Tubulointerstitial nephritis and uveitis (TINU) syndrome was suspected in males or females in their adolescent years to 30 years of age with a bilateral anterior uveitis. An elevated urine beta-2 microglobulin, increased serum creatinine, elevated erythrocyte sedimentation rate (ESR), elevated liver enzymes, anemia, and urine microscopy abnormalities were used to aid in the diagnosis of TINU.15 Additional details on patients diagnosed with TINU are provided in the Results below. Infectious causes were established with the use of laboratory testing such as a positive rapid plasma reagin (RPR) and fluorescent treponemal antibody absorption (FTA-ABS) for syphilis. For tuberculosis, we required a positive QuantiFERON TB-Gold test in association with a consistent pattern of uveitis such as granulomatous inflammation, a risk factor for acquiring tuberculosis such as birth outside the United States, or inflammation that had not responded to corticosteroids.
Demographic information was recorded based on age at presentation to our Uveitis Service. Chi-square statistical analysis was performed using free software (R Foundation for Statistical Computing, version 3.5.0, R Core Team, Vienna, Austria). P-values were computed by permutation due to small frequencies in some categories. A P-value less than 0.05 was considered statistically significant.
Results
A total of 249 patients were newly referred to the Uveitis Service of the Casey Eye Institute with a diagnosis of uveitis between 2008 and 2016. Of these, 179 (71.8%) of them were referred with a diagnosis of idiopathic uveitis. Fifty-eight of 179 (32.4%) and 121/179 (67.6%) were male and female, respectively. The ethnicity of the patients were mostly Caucasian (135/179, [75.4%]), followed by Hispanic (15/179, [8.4%]), Asian (7/179, [3.9%]), African American (6/179, [3.4%]), and other (6/179), [3.4%]). Ten patients declined revealing their ethnicity. The median age of these patients was 43 years. The age distributions included 23/179 (12.8%) for patients less than 21 years old, 53/179 (29.6%) for patients between 21 and 40 years of age, 60/179 (33.5%) for patients between 41 and 60 years of age, and 43/179 (24.0%) for patients above the age of 60 years (Figure 1). Unilateral disease was seen in 55/179 (30.7%) of patients, 113/179 (63.1%) presented with bilateral simultaneous disease, and 11/179 (6.1%) presented with bilateral alternating disease. The most common anatomic diagnosis among this group was anterior uveitis 87/179 (48.6%), followed by intermediate uveitis 65/179 (36.3%), pan-uveitis 21/179 (11.7%), and posterior uveitis 6/179 (3.4%).
Out of the 179 patients with a referral diagnosis of idiopathic uveitis, we were able to establish a diagnosis in 52/179 (29.0%) patients. Of these, 26/52 (50%) had anterior uveitis, 17/52 (32.7%) had intermediate uveitis, 3/52 (5.8%) had posterior uveitis, and 6/52 (11.5%) had pan-uveitis. These percentages resemble the percentages of the idiopathic population as a whole and indicate that we were not more successful in reclassifying idiopathic uveitis on the basis of anatomic location of inflammation.
Presumed sarcoidosis was the most common diagnosis (19/52 [36.5%]) established. The characteristics of this group are summarized in Table 1. The frequency of sarcoidosis among patients with idiopathic uveitis in our clinic has been previously published in Han et al.16 In summary, 17/19 (89.5%) of these patients had chest CT scans that revealed adenopathy strongly suggestive of sarcoidosis. One patient was presumed to have sarcoidosis based on hilar adenopathy seen on chest radiography and ocular findings consistent with sarcoidosis. Another patient was presumed to have sarcoidosis based on having the combination of an orbital mass, uveitis features consistent with sarcoidosis, and optic neuropathy. Most patients were female (16/19, [84.2%]) versus male (3/19, [15.8%]). The mean age was 55 years and the age range was between 35 and 82 years of age. Most patients were Caucasian (18/19, [94.7%]) versus African American (1/19, [5.3%]). The mean age of Caucasian patients was 56 years of age. The one African American patient was 38 years of age. An insidious onset (12/19, [63.2%]) was seen more often than a sudden presentation (7/19, [36.8%]). Unilateral presentation was seen in 2/19 (10.5%) of patients, whereas bilateral involvement was found in 17/19 (89.5%) of patients. Intermediate uveitis was the most common anatomic diagnosis seen in this group (10/19, [52.6%]), followed by anterior (5/19, [26.3%]), pan (3/19, [15.8%]), and posterior (1/19, [5.3%]). Interestingly, 4/19 (21.0%) patients whom we diagnosed with sarcoidosis were also found to have cardiac involvement after a screening EKG was ordered. All 4 patients showed ventricular tachycardia. Two of these patients (50%) had no cardiovascular symptoms, whereas the other 2 (50%) experienced palpitations that were found to be secondary to premature ventricular contractions.
Table 1.
Characteristic | Sarcoidosis (n = 19) |
HLA-B27 (n = 11) |
TINU (n = 6) |
---|---|---|---|
Anatomic Location- Number of Patients(%) Anterior Intermediate Posterior Pan |
5 (26.3%) 10 (52.6%) 1 (5.3%) 3 (15.8%) |
11 (100%) 0 0 0 |
5 (83.3%) 1 (16.7%) 0 0 |
Age - Years Mean Range |
55 35 – 82 |
49 12 – 72 |
15 10 – 30 |
Onset - Number of Patients (%) Insidious Sudden |
12(63.2%) 7 (36.8%) |
1 (9.0%) 10 (91.0%) |
1 (16.7%) 5 (83.3%) |
Laterality - Number of Patients (%) Unilateral Bilaterala |
2 (10.5%) 17 (89.5%) |
6 (54.5%) 5 (45.5%) |
0 6 (100%) |
Sex - Number of Patients (%) Female Male |
16 (84.2%) 3 (15.8%) |
6 (54.5%) 5 (45.5%) |
4 (66.7%) 2 (33.3%) |
Includes patients who had involvement of both eyes but not necessarily simultaneously
The next most common diagnosis established was HLA-B27 associated anterior uveitis (11/52, [21.2%]). The characteristics of this group are summarized in Table 1. All patients had positive testing for HLA-B27. There was an approximately equal male to female ratio (5/11, [45.5%] males; 6/11, [54.5%] females). The mean age was 49 and age range was between 12 and 72 years of age. Ten out of the 11 (91.0%) patients had sudden onset disease, whereas only 1/11 (9.0%) was insidious. Unilateral disease was seen in 6/11 (54.5%) patients, and bilateral disease was seen in 5/11 (45.5%) of patients. Of the patients with bilateral disease, two were chronic and persistent, whereas the rest were acute recurrent alternating. All eleven patients (100%) had an anatomic diagnosis of anterior uveitis.
TINU was the third most common diagnosis to replace idiopathic uveitis in 6/52 (11.5%) patients. The characteristics of this group are summarized in Table 1. The mean age was 15 and the age range was between 10 and 30 years of age. Four of the 6 were females (66.7%). The onset was sudden in 5/6 cases (83.3%) and insidious in 1/6 (16.7%) of cases. All patients 6/6 (100%) had a bilateral presentation. Five of the 6 patients (83.3%) had anterior uveitis and one patient (16.7%) had intermediate uveitis. Four patients had an elevated beta-2 microglobulin level, which helped to establish the diagnosis. One patient had presumed TINU based on their bilateral presentation, young age of 10 years, female gender, elevated alanine transaminase and aspartate transaminase, elevated creatinine level, and elevated urine leukocyte count. Another patient was presumed to have TINU based on her bilateral presentation, young age of 10 years, female gender, mild anemia, elevated ESR, elevated urinary leukocyte esterase, and prodrome of fatigue and abdominal pain. This patient was on oral corticosteroids for 4 months prior to her first appointment with our uveitis service, which could have masked any renal inflammation.
An infectious cause was identified in 6/52 (11.5%) of cases. This included herpes virus-associated anterior uveitis (1/6, [16.7%]), acute retinal necrosis (1/6, [16.7%]), tuberculosis-associated pan-uveitis (3/6, [50%]), syphilis-associated anterior and intermediate uveitis (1/6, [16.7%]). JIA-associated anterior uveitis was established in 4/52 (7.7%) of cases. The remainder of patients with an identifiable cause of uveitis included patients with Behcet’s disease, multifocal choroiditis and pan-uveitis, punctate inner choroidopathy, Crohn’s disease, multiple sclerosis, and relapsing polychondritis.
Though we were able to establish a diagnosis in many of the cases with a referral diagnosis of idiopathic uveitis, the majority of these patients (127/179, [71.0%]) were still deemed to have a diagnosis of idiopathic uveitis despite further evaluation by our team. A chi-square analysis was performed to determine whether males and females were represented across all diagnoses (sarcoidosis, HLA-B27, TINU, JIA, infectious, other, idiopathic) after evaluation proportionally to their numbers in the sample. The analysis produced a non-significant χ2 value (χ2 = 8.41, p = 0.30), indicating that neither males nor females were overrepresented in any of the groups. There was a significant association between type of onset (sudden vs. insidious) and the diagnosis (χ2 = 27.14, p = 0.0005), as well as between the anatomic location (anterior, intermediate, posterior, and pan) and the diagnosis (χ2 = 55.64, p = 0.002).
Discussion
Idiopathic uveitis is the predominant diagnosis in most series from tertiary clinics. Past studies have shown that the percentage of patients with this diagnosis ranges from 24.2% to 52.5%.3–8 Even the more recent VISUAL I and VISUAL II studies revealed that idiopathic uveitis is the most common diagnosis across uveitis centers, reporting it to be 37.3% and 36%, respectively.9, 10 The term idiopathic is unsatisfying to patients because it implies the treating physician has a limited understanding of the disease process. The label, idiopathic, is not confined to uveitis. For example, many patients with nonspecific orbital inflammation or pseudotumor are labelled as having idiopathic orbital inflammation. The term, idiopathic, often becomes embedded into how a disease is known. For example, DISH is diffuse idiopathic skeletal hyperostosis and IPF is idiopathic pulmonary fibrosis. In this study, we sought to determine the percentage of patients initially referred to our uveitis clinic with a diagnosis of idiopathic uveitis who were subsequently found to have an identifiable cause of uveitis. We report that 71.8% (179/249) of all referred patients had an initial diagnosis of idiopathic uveitis. Of these cases, a diagnosis was established in 29.0% (52/179). The three leading diagnoses established were sarcoidosis, HLA-B27-associated, and TINU.
Sarcoidosis is an autoimmune disorder primarily characterized by non-caseating granulomatous inflammation of multiple organ systems. Approximately 25–60% of patients with systemic sarcoidosis have ocular manifestations. As we reported previously, 36.5% (19/52) of patients with a referral diagnosis of idiopathic uveitis were found to have sarcoidosis.16 Of these, 21.0% (4/19) were found to have cardiac involvement with EKG testing, all of whom eventually required intra-cardiac defibrillator implantation. A diagnosis of sarcoidosis was found in all 4 of these patients with the use of chest CT imaging. These results substantiate the importance of utilizing CT chest imaging as a screening modality in patients for whom sarcoidosis is a likely diagnosis based on review of systems and features of uveitis as has been noted in a previous study from the Cole Eye Institute.17 Furthermore, we recommend that all patients with a diagnosis of sarcoidosis obtain an EKG to screen for any potentially life threatening arrhythmia. Despite the superiority of chest CT imaging compared to routine radiographs, we are reluctant to order a chest CT scan in a patient under 40 years of age due to the radiation exposure from the procedure.
HLA-B27-associated is the most common diagnosis in non-infectious anterior uveitis. HLA-B27 is a protein expressed on the cell surfaces seen in roughly 8% of the Caucasian population and up to 5% in African and Asian populations.18–21 Most patients who are HLA-B27 positive do not manifest any inflammatory manifestations; however, as many as 20% can develop seronegative spondyloarthropathies, which include ankylosing spondylitis and reactive arthritis. Since many individuals are HLA-B27 positive without evidence for disease, merely identifying someone as HLA-B27 positive does not establish a diagnosis. We considered a patient to have HLA-B27-associated disease if we also identified spondyloarthropathy or if the eye inflammation fit with the recognized pattern of HLA-B27-associated uveitis as described in the methods section. In our series, 6.1% (11/179) of patients with a referral diagnosis of idiopathic uveitis were found to have HLA-B27 associated uveitis. Two patients were eventually found to have ankylosing spondylitis after further evaluation by a rheumatologist. Another patient had a history of reactive arthritis without any ocular manifestations. Prior studies have shown that a large portion of HLA-B27 positive patients with anterior uveitis were subsequently found to have spondyloarthritis and were unaware that their chronic back pain was related to their eye inflammation. The SENTINEL study found that 69.8% and 21.9% of HLA-B27 positive patients with anterior uveitis had undiagnosed axial and peripheral spondyloarthropathy, respectively, according to Assessment of Ankylosing Spondylitis (ASAS) criteria.22 The Dublin Uveitis Evaluation Tool (DUET) study determined that roughly 40% of patients presenting to an emergency department in Ireland with idiopathic anterior uveitis have undiagnosed spondyloarthritis.23 A proper review of systems and HLA-B27 testing are important in patients with unilateral, acute anterior uveitis to screen for any undiagnosed spondyloarthropathy, since early diagnosis and treatment of spondyloarthropathies are known to improve quality of life and outcomes.24, 25
TINU is an immune-mediated disorder characterized by acute interstitial nephritis and bilateral anterior uveitis.15, 26 It is classically seen in young females up to the age of 30 years. Systemic symptoms may include fevers, chills, arthralgias, myalgias, and fatigue prior to ocular inflammation. Urine studies can reveal an elevated urine beta-2 microglobulin, white cell casts, eosinophils, and red blood cells. Laboratory investigations may also show a high sedimentation rate (ESR), serum creatinine, and liver enzymes. In our series, a diagnosis of TINU was established in 11.5% (6/52) of patients with an initial diagnosis of idiopathic uveitis. The diagnosis was supported by an elevated urinary beta-2 microglobulin in 4 of the 6 patients. The other two were presumed to have TINU based on their clinical history and presentation as well as blood and urinalysis results consistent with the diagnosis. It is possible that the associated interstitial nephritis resolved in these two cases at the time of presentation, which would account for their normal urine beta-2 microglobulin levels. Nonetheless, a urinary beta-2 microglobulin and serum creatinine should be obtained in all patients suspected of having TINU, as one prospective study determined that the positive predictive value of having elevations in both these measurements was 100% for detecting definitive and/or probable TINU.27 However, one should keep in mind that the renal disease is transient. Therefore, beta-2 microglobulin levels in the urine and serum creatinine may no longer be elevated by the time a suspected patient is seen by an ophthalmologist. In addition, TINU is usually a disease in children whose normal serum creatinine is lower than that of adults. A study from Japan found that only 25% of children with TINU had an elevated serum creatinine.28
An infectious cause was identified in 6/52 (11.5%) of cases for whom a diagnosis was established. This included herpes virus-associated anterior uveitis, acute retinal necrosis, tuberculosis-associated pan-uveitis, and syphilis-associated anterior and intermediate uveitis. These diagnoses were made by taking a thorough history, performing a meticulous clinical examination, and utilizing serology testing selectively. The case of syphilitic uveitis revealed a positive rapid plasma reagin (RPR) and fluorescent treponemal antibody absorption (FTA-ABS) test. The two cases were presumed to be tuberculosis-associated uveitis based on ocular findings consistent with tubercular uveitis, prior residence in an endemic area for tuberculosis, and testing positive on the QuantiFERON TB-Gold assay. A presumed diagnosis of herpes virus-associated anterior uveitis was made based on clinical features consistent with this diagnosis such as elevated intraocular pressure, iris atrophy, and a history of oral ulcers. Furthermore, this patient had marked improvement of their inflammation after initiating oral acyclovir. The diagnosis of acute retinal necrosis was made by clinical history and examination findings consistent with the diagnosis. It is crucial to determine whether the cause of uveitis is infectious, as the treatment regimen requires antimicrobial agents as opposed to immunosuppressants as in the cases of non-infectious etiologies. Though deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) based molecular diagnostic testing was not used to identify infectious etiologies in our case series, the literature shows the advantages of this technology.29 Polymerase chain reaction (PCR) is a powerful technique that amplifies DNA or RNA, such as that derived from pathogens, which make them easier to detect than classic culturing techniques. This is particularly advantageous in ophthalmology where limited tissue quantity can be obtained from the aqueous humor or the vitreous. PCR analysis of aqueous and vitreous in a retrospective study was shown to have a positive predictive value of 98.7% in patients with posterior segment infectious uveitis.30 Infectious agents in this study included cytomegalovirus (CMV), herpes simplex virus (HSV), varicella zoster virus (VZV), Epstein-Barr virus (EBV), and toxoplasmosis. Another retrospective study determined that there was a relatively low diagnostic advantage to using anterior chamber paracentesis with PCR in patients with suspected viral causes of anterior uveitis.31 More sophisticated techniques, such as pan-bacterial and pan-fungal primers for ribosomal DNA sequences as well as metagenomic deep sequencing can be used to reveal infectious causes that were once thought to be idiopathic.29, 32
A limitation of our study is that the time of onset of symptoms and the presumptive diagnosis of “idiopathic uveitis” was not always documented in the referring physician’s note, which presents the possibility that elapsed time resulted in evolution of the clinical presentation, allowing for the underlying cause to be more easily identified upon arrival to our facility. However, the most common diagnoses established in our study, sarcoidosis, TINU, and HLA-B27, can be silent diseases as often their systemic signs and symptoms are not overbearingly obvious.
In conclusion, we were able to establish a diagnosis in a significant proportion of patients with a referral diagnosis of idiopathic uveitis. However, consistent with reports from other tertiary uveitis centers, idiopathic uveitis was the most common diagnosis in our case series. This is a very unsatisfying diagnosis for patients and doctors alike because it highlights the lack of understanding of the mechanism governing the disease. Judicious use of ancillary laboratory testing and sophisticated molecular techniques can help shrink this imperfect diagnosis.
Highlights.
Identifying an underlying condition associated with uveitis can be potentially lifesaving for some illnesses.
Idiopathic uveitis remained the most common diagnosis in our uveitis clinic.
Acknowledgments
Funding/Support: This research was supported by NIH grant, EY026572, the William and Mary Bauman Foundation, the Stan and Madelle Rosenfeld Family Trust, and Research to Prevent Blindness.
We are indebted to Dongseok Choi for advice about statistics and to Matthias Becker for discussion about the term idiopathic.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Financial Disclosures: James Rosenbaum consults for Gilead, UCB, Regeneron, Novartis, Abbvie, and Eyevensys. He receives support from Pfizer and the Spondylitis Association of America. He receives royalties from UpToDate. The following authors have no financial disclosures: Rene Choi and Erick Rivera-Grana.
References
- 1.Jabs DA, Busingye J. Approach to the diagnosis of the uveitides. Am J Ophthalmol 2013;156(2):228–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Jakob E, Reuland MS, Mackensen F, et al. Uveitis subtypes in a german interdisciplinary uveitis center--analysis of 1916 patients. J Rheumatol 2009;36(1):127– 36 [DOI] [PubMed] [Google Scholar]
- 3.Merrill PT, Kim J, Cox TA, Betor CC, McCallum RM, Jaffe GJ. Uveitis in the southeastern United States. Curr Eye Res 1997;16(9):865–74. [DOI] [PubMed] [Google Scholar]
- 4.Rosenbaum JT. Uveitis. An internist’s view. Arch Intern Med 1989;149(5):1173–6. [DOI] [PubMed] [Google Scholar]
- 5.Oruc S, Kaplan AD, Galen M, Kaplan HJ. Uveitis referral pattern in a Midwest University Eye Center. Ocul Immunol Inflamm 2003;11(4):287–98. [DOI] [PubMed] [Google Scholar]
- 6.Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 1996;114(5):593–9. [DOI] [PubMed] [Google Scholar]
- 7.Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis. Am J Ophthalmol 1987;103(2):131–6. [DOI] [PubMed] [Google Scholar]
- 8.Perkins ES, Folk J. Uveitis in London and Iowa. Ophthalmologica 1984;189(1–2):36–40. [DOI] [PubMed] [Google Scholar]
- 9.Jaffe GJ, Dick AD, Brezin AP, et al. Adalimumab in Patients with Active Noninfectious Uveitis. N Engl J Med 2016;375(10):932–43. [DOI] [PubMed] [Google Scholar]
- 10.Nguyen QD, Merrill PT, Jaffe GJ, et al. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet 2016;388(10050):1183–92. [DOI] [PubMed] [Google Scholar]
- 11.Nguyen QD, Merrill PT, Clark WL, et al. Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA). Ophthalmology 2016;123(11):2413–2423. [DOI] [PubMed] [Google Scholar]
- 12.Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature Working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005;140(3):509–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Herbort CP, Rao NA, Mochizuki M, members of Scientific Committee of First International Workshop on Ocular S. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm 2009;17(3):160–9. [DOI] [PubMed] [Google Scholar]
- 14.Rosenbaum JT. Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease. Clin Rheumatol 2015;34(6):999–1002. [DOI] [PubMed] [Google Scholar]
- 15.Mandeville JT, Levinson RD, Holland GN. The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol 2001;46(3):195–208. [DOI] [PubMed] [Google Scholar]
- 16.Han YS, Rivera-Grana E, Salek S, Rosenbaum JT. Distinguishing Uveitis Secondary to Sarcoidosis From Idiopathic Disease: Cardiac Implications. JAMA Ophthalmol 2018;136(2):109–115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kaiser PK, Lowder CY, Sullivan P, et al. Chest computerized tomography in the evaluation of uveitis in elderly women. Am J Ophthalmol 2002;133(4):499–505. [DOI] [PubMed] [Google Scholar]
- 18.Rosenbaum JT. New developments in uveitis associated with HLA B27. Curr Opin Rheumatol 2017;29(4):298–303. [DOI] [PubMed] [Google Scholar]
- 19.Kitamei H, Kitaichi N, Namba K, et al. Clinical features of intraocular inflammation in Hokkaido, Japan. Acta Ophthalmol 2009;87(4):424–8. [DOI] [PubMed] [Google Scholar]
- 20.Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol 2005;50(4):364–88. [DOI] [PubMed] [Google Scholar]
- 21.Bawazeer AM, Joharjy HI. The association of human leukocyte antigen B27 with anterior uveitis in patients from the western region of Saudi Arabia: a retrospective study. Clin Ophthalmol 2013;7(2107–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Juanola X, Loza Santamaria E, Cordero-Coma M, Group SW. Description and Prevalence of Spondyloarthritis in Patients with Anterior Uveitis: The SENTINEL Interdisciplinary Collaborative Project. Ophthalmology 2016;123(8):1632–1636. [DOI] [PubMed] [Google Scholar]
- 23.Haroon M, O’Rourke M, Ramasamy P, Murphy CC, FitzGerald O. A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool). Ann Rheum Dis 2015;74(11):1990–5. [DOI] [PubMed] [Google Scholar]
- 24.Barkham N, Keen HI, Coates LC, et al. Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 2009;60(4):946–54. [DOI] [PubMed] [Google Scholar]
- 25.Braun J, Brandt J, Listing J, et al. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial. Arthritis Rheum 2003;48(8):2224–33. [DOI] [PubMed] [Google Scholar]
- 26.Mackensen F, Smith JR, Rosenbaum JT. Enhanced recognition, treatment, and prognosis of tubulointerstitial nephritis and uveitis syndrome. Ophthalmology 2007;114(5):995–9. [DOI] [PubMed] [Google Scholar]
- 27.Hettinga YM, Scheerlinck LM, Lilien MR, Rothova A, de Boer JH. The value of measuring urinary beta2-microglobulin and serum creatinine for detecting tubulointerstitial nephritis and uveitis syndrome in young patients with uveitis. JAMA Ophthalmol 2015;133(2):140–5. [DOI] [PubMed] [Google Scholar]
- 28.Goda C, Kotake S, Ichiishi A, Namba K, Kitaichi N, Ohno S. Clinical features in tubulointerstitial nephritis and uveitis (TINU) syndrome. Am J Ophthalmol 2005;140(4):637–41. [DOI] [PubMed] [Google Scholar]
- 29.Taravati P, Lam D, Van Gelder RN. Role of molecular diagnostics in ocular microbiology. Curr Ophthalmol Rep 2013;1(4). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Harper TW, Miller D, Schiffman JC, Davis JL. Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis. Am J Ophthalmol 2009;147(1):140–147 e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Anwar Z, Galor A, Albini TA, Miller D, Perez V, Davis JL. The diagnostic utility of anterior chamber paracentesis with polymerase chain reaction in anterior uveitis. Am J Ophthalmol 2013;155(5):781–6. [DOI] [PubMed] [Google Scholar]
- 32.Doan T, Wilson MR, Crawford ED, et al. Illuminating uveitis: metagenomic deep sequencing identifies common and rare pathogens. Genome Med 2016;8(1):90. [DOI] [PMC free article] [PubMed] [Google Scholar]